QA: Mirati Therapeutics Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001576263_2022_Mirati_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001576263, Mirati Therapeutics Inc

  xvar xval
0 AssetsCurrent 1,507,983,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 15,824,000
3 remainder_Assets 64,947,000
4 LiabilitiesCurrent 143,658,000
5 LiabilitiesNoncurrent 48,058,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 402,910,943
9 ResearchAndDevelopmentExpense 1,554,282,125
10 remainder_Expenses 2,424,196
11 remainder_Revenues 358,041,212
12 remainder_NetIncome -541,942
13 remainder_ComprehensiveNetIncome -848,438
  yvar yval
0 Assets 1,588,754,000
1 Liabilities 191,716,000
2 Expenses 1,959,617,264
3 Revenues 358,041,212
4 StockholdersEquity 1,397,038,000
5 NetIncome -1,602,117,994
6 ComprehensiveNetIncome -1,602,542,213
7 BaseVar 2,049,759,428
8 EconomicCapitalRatiobeforeLimitedLiability 1.62
9 EconomicCapitalRatio 2.76

Edgar->Model Mapping

Feature Distribution

Change over Time